Yahoo Suche Web Suche

Suchergebnisse

  1. Suchergebnisse:
  1. Healthcare Delivery. Follow. A Swiss medical team says a new method to store livers waiting for transplant could help save many more lives. The team treated a damaged donor liver in a special machine for three days and then implanted the recovered organ into a cancer patient. A year later, the patient is doing well.

  2. 13. Feb. 2019 · Nanotechnology platforms can deliver specific therapeutics to targeted cell types and/or tissue sites and thus have the potential to engineer immune responses that are tailored to the...

    • Anil Dangi, Shuangjin Yu, Xunrong Luo
    • 2019
  3. 28. Juli 2021 · AI and technology-enabled management tools are now available throughout the transplant journey. Unfortunately, those are frequently not available at the point of decision (patient listing, organ acceptance, posttransplant clinic), limiting utilization.

    • Issac R. Schwantes, David A. Axelrod
    • 2021
  4. 13. Feb. 2019 · Nanotechnology platforms can deliver specific therapeutics to targeted cell types and/or tissue sites and thus have the potential to engineer immune responses that are tailored to the particular organ type transplanted. 6 Lastly, the acute shortage of donor organs is a growing problem in transplantation.

    • Anil Dangi, Shuangjin Yu, Xunrong Luo
    • 10.1038/s41423-019-0207-3
    • 2019
    • Cell Mol Immunol. 2019 Apr; 16(4): 334-342.
  5. Due to the unique nature of transplant surgery, there are multiple time points in which the use of a nanotherapeutic can be investigated, with current research primarily focused around either in vivo systemic delivery posttransplant or ex vivo pretreatment of the organ prior to transplantation.

  6. 11. Juli 2022 · In this review, we provide insight into the various applications of ML in transplant medicine, why these were used to evaluate a specific clinical question, and the potential of ML to transform...

  7. 25. Okt. 2022 · The goal of this review is to assess the potential of two of the most recent innovations in kidney transplant technology—the implantable bioartificial kidney (BAK) and kidney regeneration technology—in addressing the aforementioned problems related to kidney replacement for patients with ERSD.